FDA Evaluating Increased VTE Risk Associated with Yasmin, Yaz Birth Control Pills

FDA Evaluating Increased VTE Risk Associated with Yasmin, Yaz Birth Control Pills
Recent studies have revealed that woment using birth control medications containing drospirenone (such as Yasmin or Yaz) have an increased risk for developing blood clots, known as venous thromboembolism (VTE).

July 03, 2011 /Medical PR News/ -- FDA Evaluating Increased VTE Risk Associated with Yasmin, Yaz Birth Control Pills
Many medications have side effects or potential risks.

Medical Insurance